1,679 results on '"Link, Brian A."'
Search Results
2. Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
3. Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
4. Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphoma
5. Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
6. Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
7. Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
8. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments
9. Surveillance imaging during first remission in follicular lymphoma does not impact overall survival
10. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
11. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
12. Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
13. Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes
14. Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment
15. Mesenchymal Stromal Cells Facilitate Tip Cell Fusion Downstream of BMP (Bone Morphogenic Protein)-Mediated Venous Angiogenesis
16. Mesenchymal Stromal Cells Facilitate Tip Cell Fusion Downstream of BMP-Mediated Venous Angiogenesis—Brief Report
17. Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma
18. Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma
19. Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
20. Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis
21. Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
22. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
23. Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study
24. Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
25. The USH3A causative gene clarin1 functions in Müller glia to maintain retinal photoreceptors
26. RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis
27. Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
28. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
29. Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups
30. DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma
31. Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma
32. Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors
33. A genome-wide association study of marginal zone lymphoma shows association to the HLA region.
34. Repeatability and Reproducibility of In Vivo Cone Density Measurements in the Adult Zebrafish Retina
35. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
36. Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region
37. Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
38. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
39. Transformation of marginal zone lymphoma to Hodgkin lymphoma
40. MCL-027 Prognostic Role of Event-free Survival at 24 Months (EFS24) in Newly Diagnosed Mantle Cell Lymphoma (MCL)
41. IBCL-333 Follicular Lymphoma (FL) 3B Patients Have a Superior Risk of an Aggressive Disease at First Event Compared to Those With FL1–3A Treated With Front-Line R-CHOP
42. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.
43. The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
44. Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
45. POSTER: ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
46. ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
47. POSTER: MCL-063 Multicohort Study of Conditional Survival and Cause of Death After Achieving Event-Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)
48. MCL-063 Multicohort Study of Conditional Survival and Cause of Death After Achieving Event-Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)
49. Abstract P1082: The Role Of Shroom3 Protein In Cardiac Regeneration And Repair
50. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.